Lijing You

743 total citations
15 papers, 482 citations indexed

About

Lijing You is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lijing You has authored 15 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Lijing You's work include Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Lijing You is often cited by papers focused on Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Lijing You collaborates with scholars based in United States. Lijing You's co-authors include Hing C. Wong, Peter R. Rhode, Jack O. Egan, Bai Liu, Nanette H. Bishopric, Xiaoyun Zhu, Lin Kong, Kaiping Han, Jinghai Wen and Emily K. Jeng and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Circulation Research.

In The Last Decade

Lijing You

14 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lijing You United States	7	281	181	135	99	70	15	482
Édgar Garavito Colombia	8	303 1.1×	238 1.3×	87 0.6×	16 0.2×	29 0.4×	9	509
Leyla Develioglu France	8	442 1.6×	70 0.4×	110 0.8×	98 1.0×	83 1.2×	10	581
N. Shamsadeen United Kingdom	4	413 1.5×	100 0.6×	145 1.1×	66 0.7×	11 0.2×	8	648
F Le Deist France	16	411 1.5×	96 0.5×	123 0.9×	25 0.3×	27 0.4×	28	607
Lan Wu United States	7	323 1.1×	23 0.1×	98 0.7×	41 0.4×	118 1.7×	10	480
Avantika S. Chitre United States	6	253 0.9×	222 1.2×	68 0.5×	37 0.4×	24 0.3×	8	387
Till S. M. Mathan Netherlands	9	440 1.6×	128 0.7×	133 1.0×	22 0.2×	13 0.2×	9	567
Oliver Schönborn‐Kellenberger United States	8	65 0.2×	155 0.9×	230 1.7×	20 0.2×	26 0.4×	27	403
Jennifer B. Meko United States	11	249 0.9×	259 1.4×	81 0.6×	37 0.4×	158 2.3×	13	648
Y Norihisa United States	8	293 1.0×	82 0.5×	96 0.7×	19 0.2×	15 0.2×	13	407

Countries citing papers authored by Lijing You

Since Specialization

Citations

This map shows the geographic impact of Lijing You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijing You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijing You more than expected).

Fields of papers citing papers by Lijing You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijing You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijing You. The network helps show where Lijing You may publish in the future.

Co-authorship network of co-authors of Lijing You

This figure shows the co-authorship network connecting the top 25 collaborators of Lijing You. A scholar is included among the top collaborators of Lijing You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijing You. Lijing You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhu, Xiaoyun, Qiongzhen Li, Niraj Shrestha, et al.. (2023). A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice. Frontiers in Immunology. 14. 1114802–1114802. 6 indexed citations

Chaturvedi, Pallavi, Niraj Shrestha, Meng Wang, et al.. (2022). Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells. Molecular Therapy. 30(3). 1171–1187. 21 indexed citations

Zhu, Xiaoyun, et al.. (2020). A Novel IL2-based Immunotherapeutic Protein Prevents the Development of Atherosclerosis in ApoE−/− mice and LDLR−/− mice. The Journal of Immunology. 204(1_Supplement). 159.19–159.19. 1 indexed citations

Shrestha, Niraj, Pallavi Chaturvedi, Gilles M. Leclerc, et al.. (2020). A novel, non-feeder-cell approach to generate large numbers of Cytokine-Induced Memory-Like NK cells for adoptive cells therapies. The Journal of Immunology. 204(1_Supplement). 88.7–88.7. 2 indexed citations

Liu, Bai, Pallavi Chaturvedi, Meng Wang, et al.. (2020). A Novel Bifunctional Fusion Protein Comprising of TGF-βRII trap and IL15/IL-15Rα as an Immunotherapeutic against Cancer. The Journal of Immunology. 204(1_Supplement). 90.12–90.12. 1 indexed citations

Liu, Bai, Lin Kong, Kaiping Han, et al.. (2017). Novel antitumor complexes of bispecific antibodies using ALT-803 as a scaffold demonstrate Tetra-specific binding activities. The Journal of Immunology. 198(Supplement_1). 120.12–120.12. 1 indexed citations

Rhode, Peter R., Jack O. Egan, Wenxin Xu, et al.. (2015). Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models. Cancer Immunology Research. 4(1). 49–60. 170 indexed citations

Gomes-Giacoia, Evan, Makito Miyake, Steve Goodison, et al.. (2014). Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion. PLoS ONE. 9(6). e96705–e96705. 78 indexed citations

Xu, Wenxin, Jack O. Egan, Bai Liu, et al.. (2014). Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). P123–P123. 1 indexed citations

10.

Doria‐Rose, Nicole A., Rachel M. Klein, Stephen A. Migueles, et al.. (2012). Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4⁺T Cells Is Directly Associated with the Magnitude of Surface IgG Binding. Journal of Virology. 86(16). 8672–8680. 84 indexed citations

11.

Wong, Hing C., Jinghai Wen, Lijing You, et al.. (2012). Intravenous administration of a novel IL-2 fusion protein, ALT-801, inhibits bladder cancer in mouse models (46.35). The Journal of Immunology. 188(1_Supplement). 46.35–46.35. 1 indexed citations

12.

Wen, Jinghai, Xiaoyun Zhu, Bai Liu, et al.. (2008). Targeting activity of a TCR/IL-2 fusion protein against established tumors. Cancer Immunology Immunotherapy. 57(12). 1781–1794. 23 indexed citations

13.

You, Lijing, Kaiping Han, Hyung‐il Lee, et al.. (2007). Peptide-loading enhancement for antigen presenting cells (93.6). The Journal of Immunology. 178(1_Supplement). S167–S167. 1 indexed citations

14.

Miller, Todd, Lijing You, Robert J. Myerburg, Paul J. Benke, & Nanette H. Bishopric. (2007). Whole blood RNA offers a rapid, comprehensive approach to genetic diagnosis of cardiovascular diseases. Genetics in Medicine. 9(1). 23–33. 21 indexed citations

15.

Turner, Mark S., Guy A. Haywood, Péter Andréka, et al.. (2004). Reversible Connexin 43 Dephosphorylation During Hypoxia and Reoxygenation Is Linked to Cellular ATP Levels. Circulation Research. 95(7). 726–733. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact